Experimental Breast Cancer Drug Shows Promise in Treating NSC Lung Cancer
A clinical trial using PARP inhibitors to treat breast and ovarian cancers actually showed promise in the treatment of some forms of lung cancer
A clinical trial using PARP inhibitors to treat breast and ovarian cancers actually showed promise in the treatment of some forms of lung cancer